Vascular Graft Solutions
General Data
Reg Number
514208966
Sector
Medical Devices
Established
2009
No. of Employees
18
Stage
Initial Revenues
Additional Funding
1
Description
Vascular Graft Solutions (VGS) was established in 2009, with the aim of improving the results of coronary revascularization procedures by developing innovative technologies. Using a research-driven approach, we have effectively addressed difficult and com
Technology
VIOLA™ is a new generation of clampless proximal anastomosis system that combines a standard punching mechanism with optimal sealing during anastomosis construction. It allows surgeons to minimize aortic manipulations during proximal anastomosis suturing that can lead to neurologic complications. VIOLA™ is FDA cleared for sale in the US and CE marked.
Targeted Customers
Hospitals, Surgeons, Healthcare Providers. VGS develops innovative solutions to improve the outcomes of coronary and peripheral bypass surgeries, arterial reconstruction, and arteriovenous fistulas in hemodialysis patients.
Management personnel
Eyal Orion - CEO & Co-Founder
Winning details
Route name
Winning year
The Expedited Program
The Expedited Program
2023